keyword
https://read.qxmd.com/read/36857947/-bullous-pemphigoid-associated-with-dipeptidil-peptidase-4-inhibitors
#1
JOURNAL ARTICLE
Agnès Garriga Casanovas
No abstract text is available yet for this article.
February 27, 2023: Atencion Primaria
https://read.qxmd.com/read/36842360/-association-between-bullous-pemphigoid-and-dipeptidyl-peptidase-4-inhibitors-and-impact-of-their-withdrawal
#2
JOURNAL ARTICLE
David Martín-Enguix, Ricardo Ruiz-Villaverde, Manuel Galán-Gutiérrez, Ana María Cabrerizo-Carvajal
No abstract text is available yet for this article.
February 24, 2023: Atencion Primaria
https://read.qxmd.com/read/36804951/-gliptin-associated-bullous-pemphigoid-case-report-and-literature-review
#3
Belén de Nicolás-Ruanes, Gerald Selda-Enríquez, Montserrat Fernández-Guarino, Elisabet Sánchez García
No abstract text is available yet for this article.
February 16, 2023: Revista Española de Geriatría y Gerontología
https://read.qxmd.com/read/36368587/low-dose-rituximab-for-bullous-pemphigoid-protocol-and-single-center-experience
#4
C Suárez-Carantoña, J Jiménez-Cauhé, A González-García, M Fernández-Guarino, M Asunción Ballester
BACKGROUND: Low-dose rituximab is a protocol used in several autoimmune diseases, that has also shown to be effective and safe in pemphigus vulgaris. OBJECTIVES: To study whether low-dose rituximab is also effective for bullous pemphigoid. METHODS: Patients with BP were treated with a single cycle of two infusions of rituximab 500mg at an interval of 2 weeks. Early and late end points were monitored. RESULTS: Six patients, five males and a female, with a mean age of 78...
November 8, 2022: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/36063872/dipeptidyl-peptidase-4-inhibitor-induced-bullous-pemphigoid-complicated-by-acquired-reactive-perforating-dermatosis
#5
T Gambichler, B Espey, M Doerler, R Stranzenbach
No abstract text is available yet for this article.
September 2, 2022: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/36055383/association-of-peripheral-blood-and-cutaneous-eosinophils-with-bullous-pemphigoid-disease-severity-and-treatment-outcomes
#6
JOURNAL ARTICLE
Pedro Miguel Garrido, Marta Aguado-Lobo, Pablo Espinosa-Lara, Luís Soares-Almeida, Paulo Filipe
BACKGROUND AND AIMS: A dermal inflammatory infiltrate rich in eosinophils is a prominent histological feature of bullous pemphigoid (BP) and peripheral blood eosinophilia has been documented in 50-60% of BP patients. Nevertheless, the impact of circulating and dermal infiltrate eosinophil levels on BP remains poorly understood. The main objective of this work was to investigate the association of peripheral blood and dermal infiltrate eosinophil levels with clinical and immunological characteristics of the disease...
August 30, 2022: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/35868546/low-dose-rituximab-for-bullous-pemphigoid-protocol-and-single-centre-experience
#7
C Suarez-Carantoña, J Jimenez-Cauhe, A Gonzalez-Garcia, M Fernandez-Guarino, M Asunción Ballester
BACKGROUND: Low-dose rituximab is a protocol used in several autoimmune diseases, that has also shown to be effective and safe in pemphigus vulgaris. OBJECTIVES: To study whether low-dose rituximab is also effective for bullous pemphigoid. METHODS: Patients with BP were treated with a single cycle of two infusions of rituximab 500 mg at an interval of 2 weeks. Early and late end points were monitored. RESULTS: Six patients, five males and a female, with a mean age of 78...
July 19, 2022: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/35659610/association-of-peripheral-blood-and-cutaneous-eosinophils-with-bullous-pemphigoid-disease-severity-and-treatment-outcomes
#8
JOURNAL ARTICLE
Pedro Miguel Garrido, Marta Aguado-Lobo, Pablo Espinosa-Lara, Luís Soares-Almeida, Paulo Filipe
BACKGROUND AND AIMS: A dermal inflammatory infiltrate rich in eosinophils is a prominent histological feature of bullous pemphigoid (BP) and peripheral blood eosinophilia has been documented in 50-60% of BP patients. Nevertheless, the impact of circulating and dermal infiltrate eosinophil levels on BP remains poorly understood. The main objective of this work was to investigate the association of peripheral blood and dermal infiltrate eosinophil levels with clinical and immunological characteristics of the disease...
June 2, 2022: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/35636509/dipeptidyl-peptidase-4-inhibitor-induced-bullous-pemphigoid-complicated-by-acquired-reactive-perforating-dermatosis
#9
T Gambichler, B Espey, M Doerler, R Stranzenbach
No abstract text is available yet for this article.
May 27, 2022: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/34088654/ocular-cicatricial-pemphigoid-methotrexate-as-an-initial-treatment
#10
Andrea María Smichowski, Victor Daniel Caputo, Cecilia Romeo, Estela Rivero, Natalia Soledad Morales, Gustavo Casado
OBJECTIVE: To analyse the clinical/epidemiological data, the management and the treatments established in patients with Ocular Cicatricial Pemphigoid (OCP) in a Rheumatology Service. MATERIAL AND METHODS: Review of clinical histories of patients with OCP referred by ophthalmology between 2008 and 2019. RESULTS: In our series of 27 patients, 67% were diagnosed and referred in the last 2 years. Most in Foster stage 1. Of the patients, 18.5% presented associated Sjogren's syndrome, with poor progression: 88...
January 2022: Reumatología clinica
https://read.qxmd.com/read/33454207/ocular-cicatricial-pemphigoid-methotrexate-as-an-initial-treatment
#11
Andrea María Smichowski, Victor Daniel Caputo, Cecilia Romeo, Estela Rivero, Natalia Soledad Morales, Gustavo Casado
OBJECTIVE: To analyse the clinical / epidemiological data, the management and the treatments established in patients with ocular cicatricial pemphigoid in a Rheumatology Service. MATERIAL AND METHODS: Review of clinical histories of patients with ocular cicatricial pemphigoid referred by ophthalmology between 2008 and 2019. RESULTS: In our series of 27 patients, 67% were diagnosed and referred in the last 2 years. Most in Foster stage 1. Of the patients, 18...
January 13, 2021: Reumatología clinica
https://read.qxmd.com/read/27533274/nursing-diagnoses-in-patients-with-immune-bullous-dermatosis
#12
MULTICENTER STUDY
Euzeli da Silva Brandão, Iraci Dos Santos, Regina Serrão Lanzillotti, Adriano Menis Ferreira, Mônica Antar Gamba, Luna Azulay-Abulafia
OBJECTIVE: identify nursing diagnoses in patients with immune-bullous dermatosis. METHOD: a quantitative and descriptive research, carried out in three institutions located in Rio de Janeiro and Mato Grosso do Sul, Brazil, using the Client Assessment Protocol in Dermatology during a nursing consultation. Simple descriptive statistics was used for data analysis. RESULTS: 14 subjects participated in the study, nine with a diagnosis of pemphigus vulgaris, pemphigus two and three of bullous pemphigoid...
August 15, 2016: Revista Latino-americana de Enfermagem
https://read.qxmd.com/read/16715768/-ocular-penfigoid-scar
#13
JOURNAL ARTICLE
Alejandro Malbran, Martín H Devote
No abstract text is available yet for this article.
2006: Medicina
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.